Seeking Alpha

Galena Biopharma (GALE) +6% premarket as it receives a patent from Japan for a Composition of...

Galena Biopharma (GALE) +6% premarket as it receives a patent from Japan for a Composition of Matter and Method of Treatment patent covering Folate Binding Protein peptide variants for use alone or in combination with FBP cancer vaccine E39. The Japanese patent provides exclusivity in the country until 2022, with additional worldwide patent filings pending.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|